Founded and funded Valisure in 2015 with a team of Yale entrepreneurs. Developed a novel analytical technology for the precision analysis of pharmaceuticals which received full ISO 17025 accreditation and 3 patent filings. Secured an unprecedented combination of FDA, DEA and state licenses and registrations to launch a truly novel and disruptive business model that combines both analytical laboratory and pharmacy. Spearheaded the rapid growth and financing of the company and put the major components in motion to launch the nation's first digital pharmacy that dispenses only chemically validated medications in 2018.
Manage product commercialization and life cycle for advanced technology development programs of Ion Torrent's semiconductor sequencing platform. Closely connect with R&D to provide insight and direction based on market and technical expertise. Successfully completed development and commercially launched Ion's flagship technology program.
Lead R&D team to develop Ion Sphere technology for commercial launch. Invented new manufacturing processes enabling Ion Sphere improvements to increase sequencing output a further 4X. Facilitate the expansion of bead efforts at other Life sites and the development of the Proton program.
Establish proof of principle for Ion Torrent Technology. Co-inventor of "Ion Spheres" enabling 4X signal boost on Ion platform. Spear headed Ion Sphere development and leveraged small team to invent novel manufacturing processes and analytical methods.